Page last updated: 2024-11-01

nylidrin and Schistosomiasis

nylidrin has been researched along with Schistosomiasis in 1 studies

Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.

Schistosomiasis: Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fayez, MA1
el-Saadani, AM1
el-Gengehy, MT1
Aziz, S1
Othman, O1
Habib, EM1

Other Studies

1 other study available for nylidrin and Schistosomiasis

ArticleYear
Effect of vasoactive drugs on hepatic haemodynamics in bilharzial liver cirrhosis.
    The Journal of the Egyptian Medical Association, 1972, Volume: 55, Issue:8

    Topics: Adolescent; Adult; Aminophylline; Dihydroxyphenylalanine; Female; Humans; Liver Circulation; Liver C

1972